NEW TECHNOLOGIES FOR THE TREATMENT OF TYPE I DIABETES DURING PREGNANCY
Main Article Content
Abstract
New technologies are opening up promising opportunities for the treatment of type I diabetes during pregnancy. Recent evidence suggests that continuous glucose monitoring (CGM) should be offered to all women receiving intensive insulin therapy early in pregnancy, which records changes in blood glucose concentration every 5 minutes over a long period of time. Despite studies comparing insulin pump therapy with multiple daily injections of insulin, its effectiveness in reducing the incidence of hyperglycemia and hypoglycemia, lowering glycated hemoglobin (HbA1) levels, weight control and pregnancy outcomes remains unclear. Sensor-integrated insulin delivery (also called artificial pancreas or feedback insulin delivery) during pregnancy has been shown to improve time to goal and works well despite changing insulin requirements during pregnancy.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010; 33(12): 2514-2520. DOI: 10.2337/dc10-1113
Maresh MJ, Holmes VA, Patterson CC, Young IS, Pearson DW, Walker JD, McCance DR. Diabetes and Pre-eclampsia Intervention Trial Study Group Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015; 38(1): 34-42. DOI: 10.2337/dc14-1755
Goudie RJ, Lunn D, Hovorka R, Murphy HR. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care. 2014; 37(6): e121-e122. DOI: 10.2337/dc13-2535
Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010; 53(3): 446-451. DOI: 10.1007/s00125-009-1633-z
Ushakova GA, Grebneva IS, Zakharov IS, Karas IYu, Karsaeva VV, Kubasova LA, et al. Regulatory and adaptive processes in the mother-placenta-fetus system during physiological and complicated pregnancy. Kemerovo, 2015. 283 p. Russian (Ушакова Г.А., Гребнева И.С., Захаров И.С., Карась И.Ю., Карсаева В.В., Кубасова Л.А. и др. Регуляторные и адаптационные процессы в системе мать-плацента-плод при физиологической и осложненной беременности. Кемерово, 2015. 283 с.)
Murphy HR, Bell R, Cartwright C, Curnow P, Maresh M, Morgan M, et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia. 2017; 60(9): 1668-1677. DOI: 10.1007/s00125-017-4314-3
Elgina SI, Zakharov IS, Rudaeva EV. Reproductive health of women and features of eating behavior. Fundamental and clinical medicine. 2019; 4(3): 48-53. Russian (Елгина С.И., Захаров И.С., Рудаева Е.В. Репродуктивное здоровье женщин и особенности пищевого поведения //Фундаментальная и клиническая медицина. 2019. Т. 4, № 3. С. 48-53)
Elgina SI, Zolotorevskaya OS, Zakharov IS, Moses VG, Rudaeva EV, Razumova VA, Kratovsky AYu. Cytological screening in the diagnosis of cervical cancer. Mother and Baby in Kuzbass. 2019; 3(78): 37-40. Russian (Елгина С.И., Золоторевская О.С., Захаров И.С., Мозес В.Г., Рудаева Е.В., Разумова В.А., Кратовский А.Ю. Цитологический скрининг в диагностике рака шейки матки //Мать и Дитя в Кузбассе. 2019. № 3(78). С. 37-40)
Zakharov IS, Moses VG, Fetishcheva LE, Rudaeva EV, Dodonov MV. Orphan forms of ectopic pregnancy. Siberian Medical Review. 2018; 3(111): 105-108. Russian (Захаров И.С., Мозес В.Г., Фетищева Л.Е., Рудаева Е.В., Додонов М.В. Орфанные формы внематочной беременности //Сибирское медицинское обозрение. 2018. № 3(111). С. 105-108)
Bailey TS. Clinical implications of accuracy measurements of continuous glucose sensors. Diabetes Technol Ther. 2017; 19(S2): S51-S54. DOI: 10.1089/dia.2017.0050
Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007; 30(11): 2785-2791. DOI: 10.2337/dc07-0500
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14): 1464-1476. DOI: 10.1056/NEJMoa0805017
Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017; 317(4): 371-378. DOI: 10.1001/jama.2016.19975
Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005; 63(7): 256-259
Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008; 337: a1680. DOI: 10.1136/bmj.a1680
Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013; 36(7): 1877-1883. DOI: 10.2337/dc12-2360
Secher AL, Madsen AB, Ringholm L, Barfred C, Stage E, Andersen HU, et al. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet Med. 2012; 29(2): 272-277. DOI: 10.1111/j.1464-5491.2011.03426.x
Moy FM, Ray A, Buckley BS, West HM. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes. Cochrane Database Syst Rev. 2017; 6: CD009613
Voormolen DN, DeVries JH, Franx A, Mol BW, Evers IM. Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy Childbirth. 2012; 12(1): 164. DOI: 10.1186/1471-2393-12-164
Abstracts from ATTD 2017 10th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France-February 15-18, 2017. Diabetes Technol Ther. 2017; 19(S1): A1-A133. DOI: 10.1089/dia.2017.2525.abstracts
Feig DS, Asztalos E, Corcoy R, De Leiva A, Donovan L, Hod M, et al. CONCEPTT: continuous glucose monitoring in women with type 1 diabetes in pregnancy trial: a multi-center, multi-national, randomized controlled trial - study protocol. BMC Pregnancy Childbirth. 2016; 16(1): 167. DOI: 10.1186/s12884-016-0961-5
Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt K, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017; 390(10110): 2347-2359. DOI: 10.1016/S0140-6736(17)32400-5
Law GR, Ellison GT, Secher AL, Damm P, Mathiesen ER, Temple R, et al. Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care. 2015; 38(7): 1319-1325. DOI: 10.2337/dc15-0070
Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012; 55(2): 282-293. DOI: 10.1007/s00125-011-2363-6
Kallas-Koeman MM, Kong JM, Klinke JA, Butalia S, Lodha AK, Lim KI, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014; 57(4): 681-689. DOI: 10.1007/s00125-014-3163-66
Abell SK, Suen M, Pease A, Boyle JA, Soldatos G, Regan J, et al. Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: cohort study. Diabetes Technol Ther. 2017; 19(5): 280-287. DOI: 10.1089/dia.2016.0412
Bruttomesso D, Bonomo M, Costa S, Dal Pos M, Di Cianni G, Pellicano F, et al. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab. 2011; 37(5): 426-431. DOI: 10.1016/j.diabet.2011.02.002
Neff KJ, Forde R, Gavin C, Byrne MM, Firth RG, Daly S, et al. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy. Ir J Med Sci. 2014; 183(3): 397-403. DOI: 10.1007/s11845-013-1027-6
Wender-Ozegowska E, Zawiejska A, Ozegowska K, Wroblewska-Seniuk K, Iciek R, Mantaj U, et al. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes. Aust N Z J Obstet Gynaecol. 2013; 53(2): 130-135. DOI: 10.1111/ajo.12027
Ranasinghe PD, Maruthur NM, Nicholson WK, Yeh HC, Brown T, Suh Y, et al. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis. J Women's Health (Larchmt). 2015; 24(3): 237-249. DOI: 10.1089/jwh.2014.4939
Cypryk K, Kosinski M, Kaminska P, Kozdraj T, Lewinski A. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. Pol Arch Med Wewn. 2008; 118(6): 339-344
Chen R, Ben-Haroush A, Weismann-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol. 2007; 197(4): 404 e1-404 e5. DOI: 10.1016/j.ajog.2007.06.007
Ryan EA, Al-Agha R. Glucose control during labor and delivery. Curr Diab Rep. 2014; 14(1): 450. DOI: 10.1007/s11892-013-0450-4
Drever E, Tomlinson G, Bai AD, Feig DS. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study. Diabet Med. 2016; 33(9): 1253-1259. DOI: 10.1111/dme.13106
Fresa R, Visalli N, Di Blasi V, Cavallaro V, Ansaldi E, Trifoglio O, et al. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Diabetes Technol Ther. 2013; 15(4): 328-334. DOI: 10.1089/dia.2012.0260
Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017; 5(7): 501-512. DOI: 10.1016/S2213-8587(17)30167-5
Stewart ZA, Wilinska ME, Hartnell S, Temple RC, Rayman G, Stanley KP, et al. Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med. 2016; 375(7): 644-654. DOI: 10.1056/NEJMoa1602494
Farrington C, Stewart ZA, Barnard K, Hovorka R, Murphy HR. Experiences of closed-loop insulin delivery among pregnant women with type 1 diabetes. Diabet Med. 2017; 34(10): 1461-1469. DOI: 10.1111/dme.13406
Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016; 316(13): 1407-1408. DOI: 10.1001/jama.2016.11708
Mishchenko OI, Moses VG, Kosinova MV, Blagoveshchenskaya OP, Moses KB, Rudaeva EV, Elgina SI. Gestational diabetes mellitus – modern concepts of epidemiology, pathogenesis, diagnosis and prevention of complications. Zabaikalsky Medical Bulletin. 2020; 1: 111-120. Russian (Мищенко О.И., Мозес В.Г., Косинова М.В., Благовещенская О.П., Мозес К.Б., Рудаева Е.В., Елгина С.И. Гестационный сахарный диабет – современные представления об эпидемиологии, патогенезе, диагностике и профилактике осложнений //Забайкальский медицинский вестник. 2020. № 1. С. 111-120)